SEED [Origin Agritech] 6-K: (Original Filing)

[Origin Agritech Limited (SEED) Reports Improved Second Quarter Financial Results for Three Months ended March 31, 2010 Cash and Cash Equivalents at March 31, 2010 rose 68.31% to RMB 392.13 million from RMB 232.99 million at March 31, 2009 Deferred Revenues and Advances from Customers at March 31, 2010 were RMB 734.72 million in total from RMB 608.61 million at]

By | 2016-03-10T21:07:09+00:00 May 11th, 2010|Categories: Chinese Stocks, SEC Original, SEED|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces First Quarter 2010 Financial Results Shenzhen, China — May 10, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the first quarter ended March 31, 2010. Highlights for First Quarter 2010 – Net revenues were $145.8 million, an increase of 8.7%]

OIIM [O2MICRO INTERNATIONAL] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 5,000 Item 8: 0 Item 9: 5,000 Item 11: 0.000% Item 12: HC Cusip #G6797E106 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 5,000 Item 8: 0 Item 9: 5,000 Item 11: 0.000%]

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 10, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 10, 2010 --------------------- (principal financial officer and principal accounting officer)]

By | 2016-03-03T20:20:43+00:00 May 10th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces First Quarter 2010 Financial Results Shenzhen, China May10, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the first quarter ended March31, 2010. Highlights for First Quarter 2010 Net revenues were $145.8million, anrease of 8.7% over the]

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 10, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321033110.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 10, 2010 --------------------- (principal financial officer and principal accounting officer) cphi10qex322033110.htm 5 EX-32.2]

By | 2016-02-07T23:27:08+00:00 May 10th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

XIN [Xinyuan Real Estate] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 4,182,892 Item 8: 0 Item 9: 4,182,892 Item 11: 2.770% Item 12: HC Cusip #98417P923 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 4,182,892 Item 8: 0 Item 9: 4,182,892 Item 11: 2.770%]

Skip to toolbar